Blue Cross Blue Shield of North Carolina and Cambia Health Solutions, the parent of Regence Blues plans in Washington, Oregon, Idaho and Utah, are joining forces to combine corporate and other back-end services under the Cambia name.
The move will draw close national attention because both are members of the Blue Cross Blue Shield group of insurers, which includes 36 companies. Collectively, the Blue insurers are a unique and powerful force in the industry, covering more than 100 million Americans, with deep local market share and a key role in the Affordable Care Act marketplaces. But in recent years the Blue insurers have largely sidestepped industry consolidation that created massive national players, with many remaining independent firms focused on just one state.
Lately, major mergers among Blue insurers “have been once-in-a-blue-moon types of transactions,” said Deep Banerjee, an analyst with S&P Global Ratings. “If there is a transaction, it does open the doors for others to follow….It absolutely can create momentum.”
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Japan’s Nippon Steel Eyes Year-End Close on $15B US Steel Deal Amid Political Uncertainty
Nov 7, 2024 by
CPI
Canada Orders Dissolution of TikTok’s Business Amid National Security Concerns
Nov 7, 2024 by
CPI
India Raids Amazon, Flipkart Seller Offices in Foreign Investment Probe
Nov 7, 2024 by
CPI
Canada’s Competition Bureau Seeks Public Feedback on Updated Merger Guidelines
Nov 7, 2024 by
CPI
FTC Adopts Stricter Reporting Rules for Mergers, Delays Expected in 2025
Nov 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI